-
Je něco špatně v tomto záznamu ?
Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress
N Mailand, S Bekker-Jensen, J Bartek, J Lukas
Jazyk angličtina Země Spojené státy americké
NLK
Cell Press Free Archives
od 1997-12-01 do Před 1 rokem
Free Medical Journals
od 1997 do Před 1 rokem
Free Medical Journals
od 1997 do Před 1 rokem
Open Access Digital Library
od 1997-12-01
PubMed
16885021
Knihovny.cz E-zdroje
- MeSH
- adaptorové proteiny signální transdukční fyziologie genetika MeSH
- biologické modely MeSH
- buněčné linie MeSH
- buněčný cyklus účinky léků MeSH
- cyklin A genetika metabolismus MeSH
- daunomycin farmakologie MeSH
- fibroblasty cytologie metabolismus MeSH
- fosforylace účinky léků MeSH
- jaderné proteiny genetika metabolismus MeSH
- kultivované buňky MeSH
- lidé MeSH
- malá interferující RNA genetika MeSH
- molekulární sekvence - údaje MeSH
- mutace genetika MeSH
- nádorové buněčné linie MeSH
- poškození DNA * fyziologie MeSH
- proteinkinasy * genetika metabolismus MeSH
- proteinligasy komplexu SCF genetika metabolismus MeSH
- proteiny buněčného cyklu genetika metabolismus MeSH
- sekvence aminokyselin MeSH
- sekvenční homologie aminokyselin MeSH
- transfekce MeSH
- tyrosinkinasy genetika metabolismus MeSH
- ubikvitin metabolismus MeSH
- vazebná místa genetika MeSH
- Check Tag
- lidé MeSH
We show that Claspin, an adaptor protein required for Chk1 activation, becomes degraded at the onset of mitosis. Claspin degradation was triggered by its interaction with, and ubiquitylation by, the SCFbetaTrCP ubiquitin ligase. This interaction was phosphorylation dependent and required the activity of the Plk1 kinase and the integrity of a betaTrCP recognition motif (phosphodegron) in the N terminus of Claspin. Uncoupling of Claspin from betaTrCP by mutating the conserved serines in Claspin's phosphodegron or by knocking down betaTrCP stabilized Claspin in mitosis, impaired Chk1 dephosphorylation, and delayed G2/M transition during recovery from cell cycle arrest imposed by DNA damage or replication stress. Moreover, the inability to degrade Claspin allowed partial reactivation of Chk1 in cells exposed to DNA damage after passing the G2/M transition. Our data suggest that degradation of Claspin facilitates timely reversal of the checkpoint response and delineates the period permissive for Chk1 activation during cell cycle progression.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14076766
- 003
- CZ-PrNML
- 005
- 20141023172021.0
- 007
- ta
- 008
- 141023s2006 xxu f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)16885021
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mailand, N. $u Institute of Cancer Biology and Centre for Genotoxic Stress Research, Danish Cancer Society, Strandboulevarden 49, DK-2100, Copenhagen, Denmark.
- 245 10
- $a Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress / $c N Mailand, S Bekker-Jensen, J Bartek, J Lukas
- 520 9_
- $a We show that Claspin, an adaptor protein required for Chk1 activation, becomes degraded at the onset of mitosis. Claspin degradation was triggered by its interaction with, and ubiquitylation by, the SCFbetaTrCP ubiquitin ligase. This interaction was phosphorylation dependent and required the activity of the Plk1 kinase and the integrity of a betaTrCP recognition motif (phosphodegron) in the N terminus of Claspin. Uncoupling of Claspin from betaTrCP by mutating the conserved serines in Claspin's phosphodegron or by knocking down betaTrCP stabilized Claspin in mitosis, impaired Chk1 dephosphorylation, and delayed G2/M transition during recovery from cell cycle arrest imposed by DNA damage or replication stress. Moreover, the inability to degrade Claspin allowed partial reactivation of Chk1 in cells exposed to DNA damage after passing the G2/M transition. Our data suggest that degradation of Claspin facilitates timely reversal of the checkpoint response and delineates the period permissive for Chk1 activation during cell cycle progression.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a adaptorové proteiny signální transdukční $x fyziologie $x genetika $7 D048868
- 650 02
- $a sekvence aminokyselin $7 D000595
- 650 02
- $a vazebná místa $x genetika $7 D001665
- 650 02
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 02
- $a proteiny buněčného cyklu $x genetika $x metabolismus $7 D018797
- 650 02
- $a buněčné linie $7 D002460
- 650 02
- $a nádorové buněčné linie $7 D045744
- 650 02
- $a kultivované buňky $7 D002478
- 650 02
- $a cyklin A $x genetika $x metabolismus $7 D019925
- 650 12
- $a poškození DNA $x fyziologie $7 D004249
- 650 02
- $a daunomycin $x farmakologie $7 D003630
- 650 02
- $a fibroblasty $x cytologie $x metabolismus $7 D005347
- 650 02
- $a lidé $7 D006801
- 650 02
- $a biologické modely $7 D008954
- 650 02
- $a molekulární sekvence - údaje $7 D008969
- 650 02
- $a mutace $x genetika $7 D009154
- 650 02
- $a jaderné proteiny $x genetika $x metabolismus $7 D009687
- 650 02
- $a fosforylace $x účinky léků $7 D010766
- 650 12
- $a proteinkinasy $x genetika $x metabolismus $7 D011494
- 650 02
- $a tyrosinkinasy $x genetika $x metabolismus $7 D011505
- 650 02
- $a malá interferující RNA $x genetika $7 D034741
- 650 02
- $a proteinligasy komplexu SCF $x genetika $x metabolismus $7 D044843
- 650 02
- $a sekvenční homologie aminokyselin $7 D017386
- 650 02
- $a transfekce $7 D014162
- 650 02
- $a ubikvitin $x metabolismus $7 D025801
- 700 1_
- $a Bekker-Jensen, S.
- 700 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271
- 700 1_
- $a Lukáš, Jiří $7 xx0094305
- 773 0_
- $t Molecular Cell $x 1097-2765 $g Roč. 23, č. 3 (2006), s. 307-318 $p Mol Cell $w MED00011398
- 773 0_
- $p Mol Cell $g 23(3):307-18, 2006 Aug 4 $x 1097-2765
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20141023171427 $b ABA008
- 991 __
- $a 20141023172027 $b ABA008
- 999 __
- $a ok $b bmc $g 1044835 $s 875717
- BAS __
- $a 3
- BMC __
- $a 2006 $b 23 $c 3 $d 307-318 $x MED00011398 $i 1097-2765 $m Molecular cell $n Mol Cell
- LZP __
- $a NLK 2014-1/lp